THE LATEST WORD

Top Industry Stories – December 18, 2009

Posted on December 18th, 2009 | by Rxmedyn | No Comments »

Cell Therapeutics’ Pixantrone Advisory Committee May Include Updated Results Of Pivotal Trial (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.
Bristol-Myers Squibb and Mead Johnson Announce Preliminary Results of the Exchange Offer (BusinessWire)
New genes for lung disease discovered (Innovations Report)


Myriad Pharmaceuticals to Acquire Javelin Pharmaceuticals
(Globe Newswire)
Amgen Receives CHMP Positive Opinion for Prolia(TM) (Denosumab) in the European Union (Press release issued by Amgen, Inc.)
AEterna Zentaris Announces Termination of Agreement with sanofi-aventis U.S. for the Development, Commercialization and Licensing of Cetrorelix in Benign Prostatic Hyperplasia (Press release issued by AEterna)
Pfizer, Boehringer Ingelheim’s Spiriva gains additional FDA approval for COPD (Associated Press)
Ariad rounds out phase 3 cancer study (Charlotte Business Journal
Merck acquires Avecia Biologics (PharmaTimes)
Roche diabetes drug meets endpoints (PharmaTimes)
Swiss plan to donate, sell on swine flu vaccines (Reuters)

Leave a Reply

You must be logged in to post a comment.